Rivaroxaban 2.5mg Shows Strong Mortality Benefit Following STEMI
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of the American College of Cardiology
Only registered members have full access to PracticeUpdate content.